
Banmédica is the flagship isapre health insurance brand of Empresas Banmédica, Chile's largest private healthcare holding. The group was controlled by UnitedHealth Group from 2018 until November 2025, when UHG agreed to sell it to a consortium of Brazil's Patria Investments and Chile's Linzor Capital Partners, a transaction that received its final regulatory approval in November 2026.
Parent Company
Acquired
2018
Status
Private
Headquarters
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Banmédica | Empresas Banmédica (Banmédica S.A.) | Subsidiary |
The organization's roots go to 1981, when private health services were organized for employees of the Caja Bancaria de Pensiones, the pension institution for Chilean banking workers. Banmédica was constituted as an open corporation in January 1988 and privatized that year, with ownership distributed among doctors (36 percent), employees (30 percent), and private investors (34 percent). Its principal early assets were Clínica Dávila and Clínica Santa María.
In 1990, the group restructured as a holding and created Isapre Banmédica S.A., concentrating its private health insurance activity in the new entity, while the Banrenta life insurer followed in 1991. Through the 1990s it expanded its clinic network, merged with Inversiones Las Américas and Inversiones Clínicas to form the country's largest health services company, and began international operations including a Peruvian pension fund stake and an Argentine social security venture.
The 2000s brought consolidation into a dominant integrated model: isapres Banmédica and Vida Tres on the insurance side, and a provider network including Clínica Santa María, Clínica Dávila, Clínica Vespucio, Clínica Biobío, Ciudad del Mar, the Vidaintegra outpatient network, and the Help mobile medical rescue service. The company was listed on the Santiago Stock Exchange for decades after joining the securities registry in 1988.
UnitedHealth Group made its tender offer for the company in December 2017, completing it on January 28, 2018, at roughly US$2.8 billion in enterprise value and achieving over 98 percent control. Banmédica shares were subsequently delisted from the Santiago exchange, though the company remained a registered bond issuer.
UHG's ownership proved transitional. On November 29, 2025, UHG signed the sale of Bordeaux Holding SpA, the vehicle controlling Banmédica's Chilean assets, plus CDC Holdings Colombia, to a consortium of Patria Investments and Linzor Capital Partners for approximately US$1 billion. Final Colombian regulatory clearance arrived on November 17, 2026, completing the approvals needed for the change of control.
What is Empresas Banmédica?
It is Chile's largest private healthcare holding, combining isapres Banmédica and Vida Tres with a clinic network including Santa María and Dávila, the Vidaintegra outpatient chain, Help rescue, and Colombian operations.
Who owns Banmédica now?
UnitedHealth Group sold its controlling interest to a consortium of Brazil's Patria Investments and Chile's Linzor Capital Partners, agreed in November 2025 and fully approved by regulators on November 17, 2026.
Is Banmédica a public company?
No. Its shares were delisted from the Santiago Stock Exchange after UnitedHealth's 2018 acquisition, though Banmédica S.A. remains a registered bond issuer.
What is an isapre?
An isapre is a private health insurer in Chile. Workers can pay their mandatory health contribution to an isapre such as Banmédica instead of the public FONASA system.
Where is Banmédica headquartered?
At Apoquindo 3600, floor 12, in Las Condes, Santiago, Chile, with operations across Chile and Colombia.
How many people work at Banmédica?
The group employs approximately 10,000 people across its insurers, clinics, laboratories, and rescue services in Chile and Colombia.
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Falabella | Chile | 1998 | Mass market | Latin america | All Genders |
Market Positioning: Banmédica competes with 1 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Looking for brands with different ownership structures? These similar brands are not owned by Empresas Banmédica (Banmédica S.A.), giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsOwned by DaVita Inc.
The dialysis clinic brand of DaVita Inc., treating roughly 200,000 kidney patients across about 2,600 US centers.
DaVita operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Kaiser Permanente
Kaiser Permanente is the largest nonprofit integrated managed care consortium in the United States, serving about 13.1 million members through its own hospitals, medical groups, and health plans.
Kaiser Permanente operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by ADARx Pharmaceuticals, Inc.
Biotechnology brand of ADARx Pharmaceuticals, the San Diego siRNA company that listed on Nasdaq in September 2026.
ADARx operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Adcock Ingram Holdings Limited
South African pharmaceutical brand behind Panado and Myprodol, now privately held by Bidvest and NATCO Pharma.
Adcock Ingram operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Alcon Inc.
Independent publicly traded global eye care company headquartered in Geneva, Switzerland, specializing in surgical equipment, contact lenses, and ophthalmic products. Spun off from Novartis in April 2019.
Alcon operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Alfa-Pharm CJSC
Armenia's largest pharmaceutical distributor and pharmacy chain, importing medicines from more than 70 global manufacturers since 1996.
Alfa-Pharm operates independently without a large parent corporation.
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Consumer DNA testing brand now run as a nonprofit under TTAM Research Institute following the 2025 bankruptcy sale of 23andMe Holding Co.

Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.

Abbott Laboratories' medical device business spanning cardiovascular, diabetes care (FreeStyle Libre), neuromodulation, and structural heart, generating roughly $20 billion annually.